Post-Market Bioequivalence of Generic Drug Product

Inactive 8(a) Set-Aside (FAR 19.8)
Notice ID:75F40124R00023

Post-Market Bioequivalence of Generic Drug Product 01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date. Proposals are due 10AM EST 01/24/2024

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA CENTER FOR DRUG EVALUATION AND RESEARCH
NAICS 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
  PSC   SCIENTIFIC DATA STUDIES
LOCATION:

Links ()

Attachments ()


Data sourced from SAM.gov. View Official Posting »

Notification